SMS Pharmaceuticals Shareholders Approve All 38th AGM Resolutions
SMS Pharmaceuticals Ltd 路 Annual General Meeting 路 30 Sept 2026, 6:10 pm
SMS Pharmaceuticals Shareholders Approve All 38th AGM Resolutions SMS Pharmaceuticals Limited announced that shareholders approved all seven resolutions with requisite majority at its 38th AGM held on 29th Sep'26. Key approved ordinary resolutions include adopting FY25-26 audited financial statements, declaring dividend for FY25-26, re-appointing Dr. Sunkara Venkata Satya Shiva Prasad as Director, approving cost auditor remuneration for FY26-27, and material related-party transactions with VKT Pharma Private Limited. Additionally, special resolutions passed for the re-appointment and remuneration of Ramesh Babu Potluri as Chairman & Managing Director, alongside loan provision approval to subsidiary SMS Peptides Private Limited.
Original exchange filing (PDF)
More announcements from SMS Pharmaceuticals Ltd
- Earnings Call Transcript 路 10 Nov 2026
- Investors Meet Audio Recording 路 05 Nov 2026
- Press release on Financial Results 路 05 Nov 2026
- Investor Presentation for quarter and half year ended September 30, 2026 路 04 Nov 2026
- Financial results and change in Company Secretary 路 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about General Updates 路 04 Nov 2026
- Change in Management_Company Secretary 路 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer 路 04 Nov 2026
